MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,097,000 | -8.0% | 42,460 | -26.8% | 0.05% | -31.0% |
Q3 2016 | $1,193,000 | -62.0% | 57,986 | -43.5% | 0.07% | -60.8% |
Q2 2016 | $3,139,000 | +123.7% | 102,590 | +173.7% | 0.18% | +86.6% |
Q1 2016 | $1,403,000 | -16.7% | 37,485 | -16.6% | 0.10% | -4.0% |
Q3 2015 | $1,685,000 | +73.5% | 44,970 | +57.5% | 0.10% | +83.6% |
Q2 2015 | $971,000 | -41.1% | 28,553 | -38.7% | 0.06% | -45.5% |
Q1 2015 | $1,648,000 | -13.4% | 46,545 | -16.6% | 0.10% | -35.3% |
Q4 2014 | $1,902,000 | -13.3% | 55,829 | -1.9% | 0.16% | +4.7% |
Q3 2014 | $2,195,000 | +301.3% | 56,922 | +255.8% | 0.15% | +55.2% |
Q1 2014 | $547,000 | -82.4% | 16,000 | -87.9% | 0.10% | -83.4% |
Q3 2013 | $3,100,000 | +167.5% | 131,925 | +205.9% | 0.58% | +233.5% |
Q2 2013 | $1,159,000 | – | 43,129 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |